{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:20:06Z","timestamp":1792016406181,"version":"4.4.0"},"reference-count":139,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug-induced interstitial lung disease (DI-ILD) encompasses a heterogeneous spectrum of potentially severe pulmonary toxicities associated with various pharmacological agents. Diagnosis is often delayed due to nonspecific symptoms and imaging findings that can mimic other ILDs or infections, particularly in patients receiving oncological or immunomodulatory therapies. Novel approaches are needed to improve early recognition and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a non-systematic, narrative literature review across major biomedical databases up to June 2025, aimed at describing current and emerging applications of artificial intelligence (AI) and radiomics in the early diagnosis, risk stratification, and personalised management of DI-ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Radiomics applied to computed tomography and positron emission tomography\/computed tomography enables extraction of high-dimensional quantitative features capturing subclinical alterations undetectable by visual assessment. In DI-ILD (particularly immune checkpoint inhibitor-related pneumonitis), radiomic models show potential diagnostic utility in distinguishing overlapping imaging patterns and predicting fibrotic progression. Integration with clinical, radiological and pharmacogenomic data has improved model performance in several studies. Additionally, AI approaches, including convolutional neural networks and ensemble learning methods, demonstrate promise in enhancing pattern recognition and risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Radiomics and AI are emerging complementary tools in multidisciplinary management of DI-ILD, offering objective imaging biomarkers and facilitating multimodal data integration to improve diagnostic precision and personalised therapeutic decisions. Nonetheless, reproducibility remains limited by variability in imaging protocols and lack of large-scale prospective multicentre validation. Clinical implementation requires standardised protocols to ensure consistency and reliability. The development of transparent, interpretable models seamlessly integrated into healthcare workflows is essential to fully leverage their real-world potential in proactive patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.01150-2025","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:55:16Z","timestamp":1764262516000},"page":"01150-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Artificial intelligence and radiomics in drug-induced interstitial lung disease"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6122-7792","authenticated-orcid":false,"given":"Guido","family":"Marchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4003-3320","authenticated-orcid":false,"given":"Salvatore Claudio","family":"Fanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4239-8267","authenticated-orcid":false,"given":"Mattia","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4002-7374","authenticated-orcid":false,"given":"Jacopo","family":"Cefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8484-3661","authenticated-orcid":false,"given":"Carmine","family":"Salerni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-6598","authenticated-orcid":false,"given":"Martina","family":"Ferioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0381-9313","authenticated-orcid":false,"given":"Piero","family":"Candoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-8784","authenticated-orcid":false,"given":"Chiara","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-7667","authenticated-orcid":false,"given":"Leonardo","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-750X","authenticated-orcid":false,"given":"Federico","family":"Cucchiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2834-6043","authenticated-orcid":false,"given":"Giovanni","family":"Cenerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0270-9742","authenticated-orcid":false,"given":"Giacomo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-6364","authenticated-orcid":false,"given":"Francesco","family":"Pistelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6953-4527","authenticated-orcid":false,"given":"Laura","family":"Carrozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-3534","authenticated-orcid":false,"given":"Michele","family":"Mondoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"2026050501500885000_12.3.01150-2025.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02776-2021"},{"key":"2026050501500885000_12.3.01150-2025.2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40261-024-01400-z","article-title":"Diagnosis and management of drug-induced interstitial lung disease in the context of anti-cancer therapy: a multidisciplinary viewpoint by Portuguese experts","volume":"44","author":"Fontes e Sousa","year":"2024","journal-title":"Clin Drug Investig"},{"key":"2026050501500885000_12.3.01150-2025.3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.570233"},{"key":"2026050501500885000_12.3.01150-2025.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.1048"},{"key":"2026050501500885000_12.3.01150-2025.5","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00262-023-03429-z","article-title":"Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations","volume":"72","author":"Shimoda","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"2026050501500885000_12.3.01150-2025.6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40264-024-01400-0","article-title":"Drug\u2013gene risk stratification in patients with suspected drug-induced interstitial lung disease","volume":"47","author":"Drent","year":"2024","journal-title":"Drug Saf"},{"key":"2026050501500885000_12.3.01150-2025.7","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/sj.bjc.6602064","article-title":"Diagnosis and management of drug-associated interstitial lung disease","volume":"91","author":"M\u00fcller","year":"2004","journal-title":"Br J Cancer"},{"key":"2026050501500885000_12.3.01150-2025.8","doi-asserted-by":"publisher","DOI":"10.2174\/1874306401206010063"},{"key":"2026050501500885000_12.3.01150-2025.9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/life14101248","article-title":"The integration of radiomics and artificial intelligence in modern medicine","volume":"14","author":"Maniaci","year":"2024","journal-title":"Life"},{"key":"2026050501500885000_12.3.01150-2025.10","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050501500885000_12.3.01150-2025.11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/23808993.2016.1164013","article-title":"Radiomics: a new application from established techniques","volume":"1","author":"Parekh","year":"2016","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"2026050501500885000_12.3.01150-2025.12","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2589-7500(22)00230-8","article-title":"Machine learning in radiology: the new frontier in interstitial lung diseases","volume":"5","author":"Barnes","year":"2023","journal-title":"Lancet Digit Health"},{"key":"2026050501500885000_12.3.01150-2025.13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3390\/diagnostics13142333","article-title":"Beyond visual interpretation: quantitative analysis and artificial intelligence in interstitial lung disease diagnosis \u201cexpanding horizons in radiology\u201d","volume":"13","author":"Rea","year":"2023","journal-title":"Diagnostics"},{"key":"2026050501500885000_12.3.01150-2025.14","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12884"},{"key":"2026050501500885000_12.3.01150-2025.15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J Clin Med"},{"key":"2026050501500885000_12.3.01150-2025.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100404"},{"key":"2026050501500885000_12.3.01150-2025.17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.628"},{"key":"2026050501500885000_12.3.01150-2025.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013297"},{"key":"2026050501500885000_12.3.01150-2025.19","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg020"},{"key":"2026050501500885000_12.3.01150-2025.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-5-199709010-00003"},{"key":"2026050501500885000_12.3.01150-2025.21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10147-015-0834-3","article-title":"Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study","volume":"20","author":"Osawa","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"2026050501500885000_12.3.01150-2025.22","doi-asserted-by":"publisher","DOI":"10.1097\/JTO"},{"key":"2026050501500885000_12.3.01150-2025.23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cllc.2014.06.003","article-title":"Association between baseline pulmonary status and interstitial lung disease in patients with non-small-cell lung cancer treated with erlotinib \u2013 a cohort study","volume":"15","author":"Johkoh","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"2026050501500885000_12.3.01150-2025.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.09.005"},{"key":"2026050501500885000_12.3.01150-2025.25","first-page":"24","article-title":"Gemcitabine-related pneumonitis in pancreas adenocarcinoma \u2013 an infrequent event: elucidation of risk factors and management implications","volume":"15","author":"Sahin","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"2026050501500885000_12.3.01150-2025.26","first-page":"80","article-title":"Drug-induced lung disease: a brief update for radiologists","volume":"29","author":"Ufuk","year":"2023","journal-title":"Diagn Interv Radiol"},{"key":"2026050501500885000_12.3.01150-2025.27","first-page":"e20240110","article-title":"Drug-induced lung disease: a narrative review","volume":"50","author":"Bridi","year":"2024","journal-title":"J Bras Pneumol"},{"key":"2026050501500885000_12.3.01150-2025.28","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-13-39"},{"key":"2026050501500885000_12.3.01150-2025.29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/imj.14647","article-title":"Pulmonary function testing for the early detection of drug-induced lung disease: a systematic review in adults treated with drugs associated with pulmonary toxicity","volume":"50","author":"Bui","year":"2020","journal-title":"Intern Med J"},{"key":"2026050501500885000_12.3.01150-2025.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2004.05.006"},{"key":"2026050501500885000_12.3.01150-2025.31","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.10.872"},{"key":"2026050501500885000_12.3.01150-2025.32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12885-017-3285-6","article-title":"Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study","volume":"17","author":"Nakamura","year":"2017","journal-title":"BMC Cancer"},{"key":"2026050501500885000_12.3.01150-2025.33","first-page":"e2023004","article-title":"Clinical characteristics of patients with diffuse alveolar hemorrhage diagnosed by cytological examination of 1000 bronchoalveolar lavage samples","volume":"40","author":"Prasad","year":"2023","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026050501500885000_12.3.01150-2025.34","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.21037\/jtd.2017.06.96","article-title":"Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges","volume":"9","author":"Lentz","year":"2017","journal-title":"J Thorac Dis"},{"key":"2026050501500885000_12.3.01150-2025.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.12.003"},{"key":"2026050501500885000_12.3.01150-2025.36","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10263"},{"key":"2026050501500885000_12.3.01150-2025.37","first-page":"1103","article-title":"Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer","volume":"32","author":"Tamiya","year":"2012","journal-title":"Anticancer Res"},{"key":"2026050501500885000_12.3.01150-2025.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-011-1013-1"},{"key":"2026050501500885000_12.3.01150-2025.39","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.1038\/s41598-022-19887-x","article-title":"Evaluation of lung toxicity with bevacizumab using the spontaneous reporting database","volume":"12","author":"Kanbayashi","year":"2022","journal-title":"Sci Rep"},{"key":"2026050501500885000_12.3.01150-2025.40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40265-022-01736-w","article-title":"Trastuzumab deruxtecan-induced interstitial lung disease\/pneumonitis in ERBB2-positive advanced solid malignancies: a systematic review","volume":"82","author":"Abuhelwa","year":"2022","journal-title":"Drugs"},{"key":"2026050501500885000_12.3.01150-2025.41","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.ctrv.2022.102378","article-title":"Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease\/pneumonitis \u2013 focus on proactive monitoring, diagnosis, and management","volume":"106","author":"Swain","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"2026050501500885000_12.3.01150-2025.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414428"},{"key":"2026050501500885000_12.3.01150-2025.43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamaoncol.2017.2925","article-title":"Association of immune-related adverse events with nivolumab efficacy in non-small cell lung cancer","volume":"4","author":"Haratani","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026050501500885000_12.3.01150-2025.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505197"},{"key":"2026050501500885000_12.3.01150-2025.45","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12180"},{"key":"2026050501500885000_12.3.01150-2025.46","doi-asserted-by":"crossref","first-page":"857519","DOI":"10.1155\/2013\/857519","article-title":"Immune-mediated adverse events associated with ipilimumab CTLA-4 blockade therapy: the underlying mechanisms and clinical management","volume":"2013","author":"Tarhini","year":"2013","journal-title":"Scientifica"},{"key":"2026050501500885000_12.3.01150-2025.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"2026050501500885000_12.3.01150-2025.48","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00081-2016"},{"key":"2026050501500885000_12.3.01150-2025.49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.14423\/SMJ.0000000000001295","article-title":"Immune checkpoint inhibitor-related pulmonary toxicity: a comprehensive review, part II","volume":"114","author":"Bukamur","year":"2021","journal-title":"South Med J"},{"key":"2026050501500885000_12.3.01150-2025.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709937"},{"key":"2026050501500885000_12.3.01150-2025.51","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jtho.2022.07.1148","article-title":"Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC: the phase 2 PACIFIC-6 trial","volume":"17","author":"Garassino","year":"2022","journal-title":"J Thorac Oncol"},{"key":"2026050501500885000_12.3.01150-2025.52","first-page":"100586","article-title":"Pneumonitis during durvalumab consolidation therapy affects survival in stage III NSCLC","volume":"4","author":"Kinehara","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"2026050501500885000_12.3.01150-2025.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.04.177"},{"key":"2026050501500885000_12.3.01150-2025.54","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz077"},{"key":"2026050501500885000_12.3.01150-2025.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.05.035"},{"key":"2026050501500885000_12.3.01150-2025.56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5045\/br.2021.2021117","article-title":"A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities","volume":"56","author":"Nekoukar","year":"2021","journal-title":"Blood Res"},{"key":"2026050501500885000_12.3.01150-2025.57","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00277-024-05760-6","article-title":"Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML","volume":"103","author":"Jain","year":"2024","journal-title":"Ann Hematol"},{"key":"2026050501500885000_12.3.01150-2025.58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cllc.2017.03.004","article-title":"Interstitial lung disease associated with crizotinib in patients with advanced non-small cell lung cancer: independent review of four PROFILE trials","volume":"18","author":"Yoneda","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"2026050501500885000_12.3.01150-2025.59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.lungcan.2013.11.016","article-title":"Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: a systematic review and meta-analysis of clinical trials","volume":"83","author":"Shi","year":"2014","journal-title":"Lung Cancer"},{"key":"2026050501500885000_12.3.01150-2025.60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12882-024-03661-4","article-title":"Sirolimus-induced pulmonary toxicity without recurrence more than 8\u2005years after everolimus replacement in a renal transplant patient with recurrent skin SCC: a case report","volume":"25","author":"Ghasemi","year":"2024","journal-title":"BMC Nephrol"},{"key":"2026050501500885000_12.3.01150-2025.61","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1314"},{"key":"2026050501500885000_12.3.01150-2025.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2015.01.007"},{"key":"2026050501500885000_12.3.01150-2025.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9629(15)40536-1"},{"key":"2026050501500885000_12.3.01150-2025.64","doi-asserted-by":"crossref","first-page":"e237571","DOI":"10.1136\/bcr-2020-237571","article-title":"Acute lung toxicity by nitrofurantoin","volume":"14","author":"Milazzo","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2026050501500885000_12.3.01150-2025.65","first-page":"e9807","article-title":"Nitrofurantoin-induced pulmonary toxicity: always review the medication list","volume":"1","author":"Batzlaff","year":"2020","journal-title":"Cureus"},{"key":"2026050501500885000_12.3.01150-2025.66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/0970-2113.116271","article-title":"Reversible interstitial lung disease with prolonged use of nitrofurantoin: do the benefits outweigh the risks?","volume":"30","author":"Singh","year":"2013","journal-title":"Lung India"},{"key":"2026050501500885000_12.3.01150-2025.67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12890-022-01926-y","article-title":"A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity","volume":"22","author":"Kwok","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026050501500885000_12.3.01150-2025.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.04.024"},{"key":"2026050501500885000_12.3.01150-2025.69","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0943"},{"key":"2026050501500885000_12.3.01150-2025.70","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70331-2"},{"key":"2026050501500885000_12.3.01150-2025.71","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"2026050501500885000_12.3.01150-2025.72","doi-asserted-by":"crossref","first-page":"1555442","DOI":"10.3389\/fmed.2025.1555442","article-title":"Use of rituximab in connective tissue disease-associated interstitial lung disease: a narrative review","volume":"12","author":"Xu","year":"2025","journal-title":"Front Med"},{"key":"2026050501500885000_12.3.01150-2025.73","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1148\/rg.2017170015","article-title":"Thoracic complications of precision cancer therapies: a practical guide for radiologists in the new era of cancer care","volume":"37","author":"Nishino","year":"2017","journal-title":"Radiographics"},{"key":"2026050501500885000_12.3.01150-2025.74","first-page":"140","article-title":"Acute eosinophilic pneumonia and bilateral pleural effusion associated with sertraline: a case report","volume":"64","author":"De Pascalis","year":"2025","journal-title":"Minerva Respir Med"},{"key":"2026050501500885000_12.3.01150-2025.75","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-010-0060-5"},{"key":"2026050501500885000_12.3.01150-2025.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2013.09.001"},{"key":"2026050501500885000_12.3.01150-2025.77","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"2026050501500885000_12.3.01150-2025.78","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002435"},{"key":"2026050501500885000_12.3.01150-2025.79","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/cancers12030546","article-title":"Association of steroids use with survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"12","author":"Petrelli","year":"2020","journal-title":"Cancers"},{"key":"2026050501500885000_12.3.01150-2025.80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.iac.2023.01.009","article-title":"Drug-induced interstitial lung diseases","volume":"43","author":"Ng","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"2026050501500885000_12.3.01150-2025.81","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07108-w"},{"key":"2026050501500885000_12.3.01150-2025.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.036"},{"key":"2026050501500885000_12.3.01150-2025.83","doi-asserted-by":"crossref","unstructured":"Harlow CA , Dwyer SJ , Lodwick G . On radiographic image analysis. In: Rosenfeld A , ed. Digital Picture Analysis. Berlin, Springer-Verlag, 1976; pp. 65\u2013150. doi:10.1007\/3540075798_21","DOI":"10.1007\/3540075798_21"},{"key":"2026050501500885000_12.3.01150-2025.84","doi-asserted-by":"publisher","DOI":"10.5152\/dir.2019.19321"},{"key":"2026050501500885000_12.3.01150-2025.85","doi-asserted-by":"crossref","first-page":"593831","DOI":"10.3389\/fonc.2020.593831","article-title":"Integrating liquid biopsy and radiomics to monitor clonal heterogeneity of EGFR-positive non-small cell lung cancer","volume":"10","author":"Cucchiara","year":"2020","journal-title":"Front Oncol"},{"key":"2026050501500885000_12.3.01150-2025.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105643"},{"key":"2026050501500885000_12.3.01150-2025.87","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.3390\/cancers14194871","article-title":"Oncologic imaging and radiomics: a walkthrough review of methodological challenges","volume":"14","author":"Stanzione","year":"2022","journal-title":"Cancers"},{"key":"2026050501500885000_12.3.01150-2025.88","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3390\/diagnostics13122020","article-title":"Artificial intelligence-based software with CE mark for chest X-ray interpretation: opportunities and challenges","volume":"13","author":"Fanni","year":"2023","journal-title":"Diagnostics"},{"key":"2026050501500885000_12.3.01150-2025.89","doi-asserted-by":"crossref","first-page":"1143256","DOI":"10.3389\/fnume.2023.1143256","article-title":"Radiomics insight into the neurodegenerative \u201chot\u201d brain: a narrative review from the nuclear medicine perspective","volume":"3","author":"Aghakhanyan","year":"2023","journal-title":"Front Nucl Med"},{"key":"2026050501500885000_12.3.01150-2025.90","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1007\/s00330-021-08485-6","article-title":"Lung vessel volume evaluated with CALIPER software is an independent predictor of mortality in COVID-19 patients: a multicentric retrospective analysis","volume":"32","author":"Romei","year":"2022","journal-title":"Eur Radiol"},{"key":"2026050501500885000_12.3.01150-2025.91","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.222893"},{"key":"2026050501500885000_12.3.01150-2025.92","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07174-0"},{"key":"2026050501500885000_12.3.01150-2025.93","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/diagnostics15040485","article-title":"Addressing multi-center variability in radiomic analysis: a comparative study of image acquisition methods across two 3T MRI scanners","volume":"15","author":"Tocil\u0103-M\u0103t\u0103\u0219el","year":"2025","journal-title":"Diagnostics"},{"key":"2026050501500885000_12.3.01150-2025.94","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-023-01572-w"},{"key":"2026050501500885000_12.3.01150-2025.95","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1007\/s00330-025-11621-1","article-title":"ESR Essentials: a step-by-step guide of segmentation for radiologists \u2013 practice recommendations by the European Society of Medical Imaging Informatics","volume":"35","author":"Chupetlovska","year":"2025","journal-title":"Eur Radiol"},{"key":"2026050501500885000_12.3.01150-2025.96","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191145"},{"key":"2026050501500885000_12.3.01150-2025.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2021.106609"},{"key":"2026050501500885000_12.3.01150-2025.98","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24898"},{"key":"2026050501500885000_12.3.01150-2025.99","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLI.0000000000000855","article-title":"Benchmarking feature selection methods in radiomics","volume":"57","author":"Demircio\u01e7lu","year":"2022","journal-title":"Invest Radiol"},{"key":"2026050501500885000_12.3.01150-2025.100","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3390\/diagnostics14222473","article-title":"Decoding radiomics: a step-by-step guide to machine learning workflow in hand-crafted and deep learning radiomics studies","volume":"14","author":"C\u00e8","year":"2024","journal-title":"Diagnostics"},{"key":"2026050501500885000_12.3.01150-2025.101","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/resp.12665","article-title":"Interstitial lung disease associated with gemcitabine: a Japanese retrospective cohort study","volume":"21","author":"Hamada","year":"2016","journal-title":"Respirology"},{"key":"2026050501500885000_12.3.01150-2025.102","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3390\/diagnostics14222531","article-title":"Feasibility of using 18F-FDG PET\/CT radiomics and machine learning to detect drug-induced interstitial lung disease","volume":"14","author":"Smith","year":"2024","journal-title":"Diagnostics"},{"key":"2026050501500885000_12.3.01150-2025.103","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0524-2"},{"key":"2026050501500885000_12.3.01150-2025.104","doi-asserted-by":"crossref","first-page":"e1822","DOI":"10.1002\/onco.13900","article-title":"Radiation versus immune checkpoint inhibitor associated pneumonitis: distinct radiologic morphologies","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist"},{"key":"2026050501500885000_12.3.01150-2025.105","doi-asserted-by":"crossref","first-page":"870842","DOI":"10.3389\/fimmu.2022.870842","article-title":"Development and validation of a radiomics nomogram using computed tomography for differentiating immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis for patients with non-small cell lung cancer","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"2026050501500885000_12.3.01150-2025.106","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mp.15451","article-title":"Differentiation between immune checkpoint inhibitor-related and radiation pneumonitis in lung cancer by CT radiomics and machine learning","volume":"49","author":"Cheng","year":"2022","journal-title":"Med Phys"},{"key":"2026050501500885000_12.3.01150-2025.107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12672-022-00548-4","article-title":"Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?","volume":"13","author":"Thomas","year":"2022","journal-title":"Discov Oncol"},{"key":"2026050501500885000_12.3.01150-2025.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.01.027"},{"key":"2026050501500885000_12.3.01150-2025.109","doi-asserted-by":"crossref","first-page":"107507","DOI":"10.1016\/j.lungcan.2024.107507","article-title":"Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: the relevance of fractionation","volume":"189","author":"Kraus","year":"2024","journal-title":"Lung Cancer"},{"key":"2026050501500885000_12.3.01150-2025.110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41698-024-00790-9","article-title":"Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC","volume":"8","author":"Delasos","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2026050501500885000_12.3.01150-2025.111","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.acra.2024.09.053","article-title":"Radiomics biomarkers to predict checkpoint inhibitor pneumonitis in non-small cell lung cancer","volume":"32","author":"Du","year":"2025","journal-title":"Acad Radiol"},{"key":"2026050501500885000_12.3.01150-2025.112","doi-asserted-by":"crossref","first-page":"e2400198","DOI":"10.1200\/CCI-24-00198","article-title":"Radiomics and deep learning prediction of immunotherapy-induced pneumonitis from computed tomography","volume":"9","author":"Smith","year":"2025","journal-title":"JCO Clin Cancer Inform"},{"key":"2026050501500885000_12.3.01150-2025.113","doi-asserted-by":"crossref","first-page":"15330338251344004","DOI":"10.1177\/15330338251344004","article-title":"Machine learning model integrating CT radiomics of the lung to predict checkpoint inhibitor pneumonitis in patients with advanced cancer","volume":"24","author":"Cousin","year":"2025","journal-title":"Technol Cancer Res Treat"},{"key":"2026050501500885000_12.3.01150-2025.114","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11604-024-01607-2","article-title":"Correlation of CT-based radiomics analysis with pathological cellular infiltration in fibrosing interstitial lung diseases","volume":"42","author":"Haga","year":"2024","journal-title":"Jpn J Radiol"},{"key":"2026050501500885000_12.3.01150-2025.115","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00330-020-07293-8","article-title":"Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept","volume":"31","author":"Martini","year":"2021","journal-title":"Eur Radiol"},{"key":"2026050501500885000_12.3.01150-2025.116","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00330-022-09187-3","article-title":"Systematic review of the radiomics quality score applications: an EuSoMII Radiomics Auditing Group Initiative","volume":"33","author":"Spadarella","year":"2023","journal-title":"Eur Radiol"},{"key":"2026050501500885000_12.3.01150-2025.117","first-page":"23333928241234863","article-title":"Artificial intelligence and decision-making in healthcare: a thematic analysis of a systematic review of reviews","volume":"11","author":"Khosravi","year":"2024","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"2026050501500885000_12.3.01150-2025.118","doi-asserted-by":"publisher","DOI":"10.7861\/fhj.2021-009551"},{"key":"2026050501500885000_12.3.01150-2025.119","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04698-z"},{"key":"2026050501500885000_12.3.01150-2025.120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/diagnostics13040688","article-title":"Artificial intelligence for medical diagnostics \u2013 existing and future AI technology!","volume":"13","author":"Al-Antari","year":"2023","journal-title":"Diagnostics"},{"key":"2026050501500885000_12.3.01150-2025.121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41746-025-01460-1","article-title":"Transforming diagnosis through artificial intelligence","volume":"8","author":"D'Adderio","year":"2025","journal-title":"NPJ Digit Med"},{"key":"2026050501500885000_12.3.01150-2025.122","first-page":"e45684","article-title":"Perspective of artificial intelligence in disease diagnosis: a review of current and future endeavours in the medical field","volume":"15","author":"Umapathy","year":"2023","journal-title":"Cureus"},{"key":"2026050501500885000_12.3.01150-2025.123","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/atm.atm_192_23","article-title":"Artificial intelligence in respiratory care: current scenario and future perspective","volume":"19","author":"Al-Anazi","year":"2024","journal-title":"Ann Thorac Med"},{"key":"2026050501500885000_12.3.01150-2025.124","doi-asserted-by":"crossref","first-page":"1502434","DOI":"10.3389\/fdgth.2024.1502434","article-title":"Artificial intelligence in respiratory care","volume":"6","author":"Karthika","year":"2024","journal-title":"Front Digit Health"},{"key":"2026050501500885000_12.3.01150-2025.125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MCP.0000000000001024","article-title":"Artificial intelligence in interventional pulmonology","volume":"30","author":"Ishiwata","year":"2024","journal-title":"Curr Opin Pulm Med"},{"key":"2026050501500885000_12.3.01150-2025.126","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00395-2024"},{"key":"2026050501500885000_12.3.01150-2025.127","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0263-2024"},{"key":"2026050501500885000_12.3.01150-2025.128","doi-asserted-by":"crossref","unstructured":"Kim C , Tatonetti N . Prediction of adverse drug reactions associated with drug\u2013drug interactions using hierarchical classification. BioRxiv 2021; preprint [https:\/\/doi.org\/10.1101\/2021.02.10.430512].","DOI":"10.1101\/2021.02.10.430512"},{"key":"2026050501500885000_12.3.01150-2025.129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00262-025-04053-9","article-title":"Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis","volume":"74","author":"Hazim","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"2026050501500885000_12.3.01150-2025.130","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2022.12.013"},{"key":"2026050501500885000_12.3.01150-2025.131","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14740338.2025.2472918","article-title":"Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs","volume":"24","author":"Hwang","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"2026050501500885000_12.3.01150-2025.132","first-page":"130","article-title":"Automatic machine learning accurately predicts the efficacy of immunotherapy for patients with inoperable advanced non-small cell lung cancer using a computed tomography-based radiomics model","volume":"31","author":"Lin","year":"2025","journal-title":"Diagn Interv Radiol"},{"key":"2026050501500885000_12.3.01150-2025.133","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2024.2329612"},{"key":"2026050501500885000_12.3.01150-2025.134","doi-asserted-by":"publisher","DOI":"10.1177\/20420986231224227"},{"key":"2026050501500885000_12.3.01150-2025.135","doi-asserted-by":"crossref","first-page":"768792","DOI":"10.3389\/fddsv.2021.768792","article-title":"Deep learning prediction of adverse drug reactions in drug discovery using open TG\u2013GATEs and FAERS databases","volume":"1","author":"Mohsen","year":"2021","journal-title":"Front Drug Discov"},{"key":"2026050501500885000_12.3.01150-2025.136","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.177.1.2399310"},{"key":"2026050501500885000_12.3.01150-2025.137","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3904\/kjim.2014.29.6.746","article-title":"The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity","volume":"29","author":"Kang","year":"2014","journal-title":"Korean J Intern Med"},{"key":"2026050501500885000_12.3.01150-2025.138","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fmed.2019.00238","article-title":"Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment","volume":"6","author":"Fragoulis","year":"2019","journal-title":"Front Med"},{"key":"2026050501500885000_12.3.01150-2025.139","doi-asserted-by":"crossref","first-page":"103228","DOI":"10.1016\/j.eclinm.2025.103228","article-title":"Artificial intelligence for diagnostics in radiology practice: a rapid systematic scoping review","volume":"83","author":"Lawrence","year":"2025","journal-title":"EClinicalMedicine"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01150-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:50:26Z","timestamp":1777971026000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01150-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":139,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5,5]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1183\/23120541.01150-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01150-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}